Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

Clinical trial NCT06559306 · RECRUITING

Trial details

NCT number: NCT06559306
Sponsor: Janssen Research & Development, LLC
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2024-07-25
Primary completion: 2026-12-30
Enrollment: 752

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.